Related Experiment Video
Updated: Mar 26, 2026

09:40
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
3.3K
One good DNA-damage deserves another: Oxaliplatin in MSI-high colon cancer
Howard S Hochster1, Daniel J Sargent2
1Yale Cancer Center and School of Medicine, New Haven CT Mayo Clinic, Rochester MN howard.hochster@yale.edu.
Journal of the National Cancer Institute
|February 7, 2016
Abstract
No abstract available in PubMed .

